References
- Potter M, Hammond JW, Sim KG, Green AK, Wilcken B. Ornithine carbamoyltransferase deficiency: Improved sensitivity of testing for protein tolerance in the diagnosis of heterozygotes. J Inherit Metab Dis. 2001; 24(1): 5-14.
- Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, et al. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet. 2001; 108(1): 66-71.
- Sarajlija A, Milenkovic M, Djordjevic K, Mitrovic S, Todorovic B, Kecman Khalid H. Early presentation of hyperinsulinism/hyperammonemia syndrome in three Serbian ptients. J Clin Res Pediatr Endocrinol. 2015; 8(2): 228-231.
- Stanley CA. Hyperinsulinism in infants and children. Pediatr Clin North Am. 1997; 44(2): 363-374.
- Senniappan S, Shanti B, James C, Hussain K. Hyperinsulinaemichypoglycaemia: Genetic mechanisms, diagnosis and management. J Inherit Metab Dis. 2012; 35(4): 589-601.
- Zschocke J, Hoffmann GF. Vademecum Metabolicum. Diagnoses and Treatment of Inborn Errors of Metabolism, 3rd ed. Friedrichsdorf (Hesse, Germany): Schattauer GmbH, 2011.
- Mathew PM, Young JM, Abu-Osba YK, Mulhern BD, Hammoudi S, Hamdan JA, et al. Persistent neonatal hyperinsulinism. Clin Pediatr (Philadelphia). 1988; 27(3): 148-151.
- Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K. Hyperinsulinaemichypoglycaemia. Arch Dis Child. 2009; 94(6): 450-457.
- Senniappan S, Arya VB, Hussain K. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocrinol Metab. 2013; 17(1): 19-30.
- Stanley CA. Hyperinsulinism/hyperammonemia syndrome: Insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab. 2004; 81(1): 45-51.
- MacMullen C, Fang J, Hsu BY, Kelly A, de Lonlay-Debeney P, Saudubray JM, et al. Hyperinsulin-ism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab. 2001; 86(4): 1782-1787.
- Kelly A, Ng D, Ferry RJ Jr, Grimberg A, Koo-McCoy S, Thornton PS, et al. Acute insulin responses to leucine in children with the hyperinsulinism/hyperammonemia syndrome. J Clin Endocrinol Metab. 2001; 86(8): 3724-3728.
- Stanley CA, Fang J, Kutyna K, Hsu BY, Ming JE, Glaser B, et al.; HI/HA Contributing Investigators. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: Predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. Diabetes. 2000; 49(4): 667-673.
- Ashcroft FM. ATP-sensitive potassium channelopathies: Focus on insulin secretion. J Clin Invest. 2005; 115(8): 2047-2058.
- Hsu BYL, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001; 138(3): 383-389.
- Stanley CA, Matschinsky FM. Historical perspective on the genetic forms of congenital hyperinsulinism. In: Stanley CA, De León DD, Eds. Monogenic Hyperinsulinemic Hypoglycemia Disorders. Frontiers in Diabetes, Vol. 21. Basel (Basel-Stadt, Switzerland): S. Karger Ag, 2012: 1-6.
- Sener A, Malaisse-Lagae F, Malaisse WJ. Stimulation of pancreatic islet metabolism and insulin release by a nonmetabolizable amino acid. Proc Natl Acad Sci USA. 1981; 78(9): 5460-5464 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC348765/).
- Gao Z, Li G, Najafi H, Wolf BA, Matschinsky FM. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes. 1999; 48(8): 1535-1542.
- Maechler P, Wollheim CB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature. 1999; 402(6762): 685-689.
- Aoki TT, Muller WA, Brennan MF, Cahill Jr GF. Blood cell and plasma amino acid levels across forearm muscle during a protein meal. Diabetes. 1973; 22(10): 768-775.
- Flanagan SE, Patch AM, Locke JM, Akcay T, Simsek E, Alaei M, et al. Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees. J Clin Endocrinol Metab. 2011; 96(3): 498-502.